Zomedica · 2 days ago
Sales Account Manager
Maximize your interview chances
Insider Connection @Zomedica
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Increase diagnostic and therapeutic capital placements and product utilization in your assigned geographic responsibility.
Achieve revenue and growth goals by acquiring new accounts and leveraging existing accounts.
Define, verify, and translate customer needs into diagnostic, point-of-care, and wellness management solutions.
Develop and grow partnerships with veterinary practice staff.
Educate and train veterinary clinic staff on products, services, and marketing initiatives.
Attend trade shows and other educational events.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s Degree in a scientific or related discipline, or an equivalent combination of related education and/or experience.
3+ years of relevant sales experience, ideally in animal health, in direct sales of diagnostic, laser, ultrasound, therapeutic, or other medical device / capital equipment.
Strong closing skills, with a proven track record of capital sales and customer service excellence.
Demonstrated ability to build strong customer relationships.
Excellent communication and interpersonal skills, with ability to work effectively in a collaborative sales environment.
Ability to travel to call points within an assigned territory.
Strong computer skills, with experience utilizing a CRM management database.
Preferred
Salesforce.com experience.
Benefits
Medical insurance
Employer-paid dental / vision / disability / life insurance
401k plan with a Company match
Generous PTO
Paid holidays
Collaborative work environment
Great growth potential
Company
Zomedica
Zomedica is a veterinary pharmaceutical company.
Funding
Current Stage
Public CompanyTotal Funding
$254.45M2021-02-08Post Ipo Equity· $173.5M
2020-07-01Post Ipo Equity· $50M
2020-02-12Post Ipo Equity· $2.5M
Recent News
2024-12-03
Company data provided by crunchbase